Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
US — Financial Services Sector
Automate Your Wheel Strategy on DMAA
With Tiblio's Option Bot, you can configure your own wheel strategy including DMAA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DMAA
- Rev/Share 0.0
- Book/Share 6.8026
- PB 1.5156
- Debt/Equity 0.0
- CurrentRatio 0.165
- ROIC -0.0026
- MktCap 345561734.0
- FreeCF/Share -0.0182
- PFCF -567.1771
- PE 101.6982
- Debt/Assets 0.0
- DivYield 0
- ROE 0.03
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
- IPO Date 2025-01-27
- Website https://dmaacorp.com
- Industry Shell Companies
- CEO Lynn Stockwell
- Employees 2
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.